Long-Term Follow-Up in Patients With Prostate Cancer After Surgery

StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed
    • Primary completion date changed from estimate of Oct 1, 2026 to Aug 10, 2026
    • Eligibility criteria expanded, about 10 words
  2. Primary and study completion pushed from Jul 28, 2026 to Oct 1, 2026v14
  3. Primary and study completion dates: Aug 25, 2025 to Jul 28, 2026v13
  4. Primary and study completion dates: Dec 30, 2024 to Aug 25, 2025v12
  5. Primary and study completion dates: Dec 30, 2023 to Dec 30, 2024v11
Show 9 earlier versionsHide 9 earlier versions
  1. Primary and study completion dates: Jun 30, 2023 to Dec 30, 2023v10
  2. Primary and study completion dates: Dec 23, 2022 to Jun 30, 2023v9
  3. Re-verified, no change to tracked fieldsv8
  4. Primary and study completion dates: Dec 23, 2021 to Dec 23, 2022v7
  5. Primary and study completion dates: Dec 2021 to Dec 23, 2021
    • Start date: Jul 2008 to Jul 23, 2008
    v6
  6. Primary and study completion dates: Jan 2019 to Dec 2021v5
  7. Re-verified, no change to tracked fieldsv4
  8. Primary and study completion dates: Feb 2018 to Jan 2019v3
  9. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This clinical trial studies how well a long-term follow-up works in patients with prostate cancer after surgery. Long-term follow-up data may serve as a resource to help ask clinical questions, describe health-related quality of life and long-term complications related, and facilitate future studies focusing on interventions to improve health status and health-related quality of life in prostate cancer survivors.
Trial Details
NCT Number NCT03035500
Lead Sponsor City of Hope Medical Center
Collaborators: National Cancer Institute (NCI)
Conditions
(from sponsor)		 Cancer Survivor, Prostate Carcinoma
Related terms Prostatic Neoplasms
Enrollment 2,500 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov